Exposure to hypoglycemia and risk of stroke

In the treatment of both type 1 and type 2 diabetes mellitus, maintaining a euglycemic state represents one of the key challenges. Improper dosing and administration of glucose‐lowering drugs is associated with an increased risk of recurrent hypoglycemia episodes. In addition, the risk of adverse cardiovascular events in diabetic patients, particularly myocardial infarctions and strokes, is well established. Current research indicates a potential link between the baseline risk of cardio/cerebrovascular events in diabetic patients and exposure to hypoglycemia. In this review of the literature, we aim to determine if a relationship exists between recurrent hypoglycemia and adverse neurovascular events.

• Publication year

  2018

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2018-06-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/nyas.13872PMID 29917249PMCID PMC6214717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potential link between post-acute ischemic stroke exposure to hypoglycemia and hemorrhagic transformation

  2020cited by this paper
• DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality

  2017cited by this paper
• Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial

  2017cited by this paper
• The Association of Severe Hypoglycemia With Incident Cardiovascular Events and Mortality in Adults With Type 2 Diabetes

  2017cited by this paper
• Diabetes microvascular complications-A clinical update.

  2017cited by this paper
• Hypoglycaemia seriousness and weight gain as determinants of cardiovascular disease outcomes among sulfonylurea users

  2017cited by this paper
• Role of oxidative stress on platelet hyperreactivity during aging.

  2016cited by this paper
• Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association

  2016cited by this paper
• Comparative effects of acute hypoglycemia and hyperglycemia on pro-atherothrombotic biomarkers and endothelial function in non-diabetic humans.

  2016cited by this paper
• Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial.

  2016cited by this paper
• The effect of frailty should be considered in the management plan of older people with Type 2 diabetes

  2016cited by this paper
• The role of leukocytes in thrombosis.

  2016cited by this paper
• Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study

  2016cited by this paper
• Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes

  2016cited by this paper
• Hypoglycaemia, a global cause for concern.

  2015cited by this paper
• Management of endocrine disease: Diabetes and osteoporosis: cause for concern?

  2015cited by this paper
• Musculoskeletal effects of diabetes mellitus.

  2015cited by this paper
• Morphologic Changes in Autonomic Nerves in Diabetic Autonomic Neuropathy

  2015cited by this paper
• Effects of Acute and Antecedent Hypoglycemia on Endothelial Function and Markers of Atherothrombotic Balance in Healthy Humans

  2015cited by this paper
• Hypoglycemia in older people - a less well recognized risk factor for frailty.

  2015cited by this paper
• Hypoglycemia-Associated Autonomic Failure in Diabetes: Maladaptive, Adaptive, or Both?

  2015cited by this paper
• Hypoglycemia in Type 2 Diabetes - More Common Than You Think

  2015cited by this paper
• Infections in diabetes.

  2015cited by this paper
• Changes in Diabetes-Related Complications in the United States

  2014cited by this paper
• In Vitro Cerebrovascular Modeling in the 21st Century: Current and Prospective Technologies

  2014cited by this paper
• Self-reported frequency and impact of hypoglycaemic events in insulin-treated diabetic patients in Austria

  2014cited by this paper
• Changes in diabetes-related complications in the United States, 1990-2010.

  2014cited by this paper
• Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease.

  2013cited by this paper
• Cardiac implications of hypoglycaemia in patients with diabetes – a systematic review

  2013cited by this paper
• Research: Complications Self-reported non-severe hypoglycaemic events in Europe

  2013cited by this paper
• Hypo- and Hyperglycemia Impair Endothelial Cell Actin Alignment and Nitric Oxide Synthase Activation in Response to Shear Stress

  2013cited by this paper
• Hypoglycemia as a Driver of Cardiovascular Risk in Diabetes

  2013cited by this paper
• Platelet-leukocyte crosstalk: Linking proinflammatory responses to procoagulant state.

  2013cited by this paper
• Action to Control Cardiovascular Risk in Diabetes

  2013cited by this paper
• Effect of tight blood glucose control versus conventional control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials.

  2013cited by this paper
• Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase‐4 inhibitors and sulphonylureas: a primary care database analysis

  2013cited by this paper
• Prognostic implications of DPP‐4 inhibitor vs. sulfonylurea use on top of metformin in a real world setting – results of the 1 year follow‐up of the prospective DiaRegis registry

  2013cited by this paper
• Insulin analogues and severe hypoglycaemia in type 1 diabetes.

  2012cited by this paper
• The role of platelets in athero-thrombotic events.

  2012cited by this paper
• Current National Patterns of Comorbid Diabetes among Acute Ischemic Stroke Patients

  2012cited by this paper
• Structure and function of the blood-brain barrier.

  2010cited by this paper
• ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY GROUP. EFFECTS OF INTENSIVE GLUCOSE LOWERING IN TYPE 2 DIABETES

  2010cited by this paper
• Effects of Acute Hypoglycemia on Inflammatory and Pro-atherothrombotic Biomarkers in Individuals With Type 1 Diabetes and Healthy Individuals

  2010cited by this paper
• Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

  2010cited by this paper
• Selective vulnerability of brain regions to oxidative stress in a non-coma model of insulin-induced hypoglycemia.

  2010cited by this paper
• Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation

  2010cited by this paper
• Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects.

  2009cited by this paper
• Oral antidiabetic agents: anti-atherosclerotic properties beyond glucose lowering?

  2009cited by this paper
• Endothelial Dysfunction, Vascular Disease and Stroke: The ARTICO Study

  2009cited by this paper
• Glucose Regulation in Acute Stroke Patients (GRASP) Trial: A Randomized Pilot Trial

  2009cited by this paper
• Glucose control and vascular complications in veterans with type 2 diabetes.

  2009cited by this paper
• Sequential Release of Nitric Oxide, Zinc, and Superoxide in Hypoglycemic Neuronal Death

  2008cited by this paper
• Mitochondrial free radical production induced by glucose deprivation in cerebellar granule neurons

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Treatment of Hyperglycemia In Ischemic Stroke (THIS): A Randomized Pilot Trial

  2008cited by this paper
• Mitochondrial free radical production induced by glucose deprivation in cerebellar granule neurons

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

  2007cited by this paper
• Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus: The Framingham Heart Study

  2007cited by this paper
• Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration

  2007cited by this paper
• Hypoglycaemia predisposes platelets to death by affecting calcium homeostasis and mitochondrial integrity

  2007cited by this paper
• Plasma endothelin response to acute hypoglycaemia in adults with Type 1 diabetes

  2007cited by this paper
• Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase.

  2007cited by this paper
• Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK).

  2007cited by this paper
• The musculoskeletal effects of diabetes mellitus.

  2006cited by this paper
• Increased mitochondrial reactive oxygen species production in newborn brain during hypoglycemia.

  2006cited by this paper
• Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia.

  2005cited by this paper
• Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study.

  2005cited by this paper
• The Blood-Brain Barrier/Neurovascular Unit in Health and Disease

  2005cited by this paper
• Frequency and predictors of hypoglycaemia in Type 1 and insulin‐treated Type 2 diabetes: a population‐based study

  2005cited by this paper
• Stroke patterns, etiology, and prognosis in patients with diabetes mellitus

  2004cited by this paper
• Stroke in Patients With Diabetes

  2004cited by this paper
• Authors' Voluntary Retraction: H. Wilkie, A. Osei-Lah, B. Chioza, L. Nashef, D. McCormick, P. Asherson, and A.J. Makoff: Association of the μ-opioid receptor subunit gene and idiopathic generalized epilepsy. Neurology 2002;59:724–728

  2004cited by this paper
• Oxidative stress in the brain tissue of laboratory mice with acute post insulin hypoglycemia.

  2003cited by this paper
• Hypoglycaemia in insulin‐treated Type 2 diabetes: frequency, symptoms and impaired awareness

  2003cited by this paper
• Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes.

  2003cited by this paper
• Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes.

  2002cited by this paper
• Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.

  2002cited by this paper
• Urinary 11-dehydro-thromboxane B(2) and coagulation activation markers measured within 24 h of human acute ischemic stroke.

  2001cited by this paper
• Infections in diabetes.

  2001cited by this paper
• Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus < 12 h) stroke patients: the West Birmingham Stroke Project

  2001cited by this paper
• Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes.

  2001cited by this paper
• Activated coagulation/fibrinolysis system and platelet function in acute thrombotic stroke patients with increased C-reactive protein levels.

  2000cited by this paper
• Diabetes and cardiovascular disease.

  1999cited by this paper
• Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.

  1998cited by this paper
• Alterations of Platelet, Coagulation, and Fibrinolysis Markers in Patients with Acute Ischemic Stroke

  1997cited by this paper
• Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.

  1997cited by this paper
• Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group.

  1997cited by this paper
• Hypoglycemia in the Diabetes Control and Complications Trial

  1997cited by this paper
• Tumor necrosis factor-alpha induces activation of coagulation and fibrinolysis in baboons through an exclusive effect on the p55 receptor.

  1996cited by this paper
• The Effect of Insulin-Induced Hypoglycaemia on Factor VIII: C Concentrations and Thrombin Activity in Subjects with Type 1 (Insulin-Dependent) Diabetes

  1995cited by this paper
• Hemostatic disturbances in acute ischemic stroke: a study of 86 patients.

  1995cited by this paper
• Stroke in Patients With Diabetes The Copenhagen Stroke Study

  1994cited by this paper
• Frequency and Morbidity of Severe Hypoglycaemia in Insulin‐treated Diabetic Patients

  1993cited by this paper
• Diabetes and the risk of stroke.

  1993cited by this paper
• Effects of oral hypoglycaemic agents on platelet functions.

  1992cited by this paper
• Effects of oral hypoglycaemic agents on platelet functions.

  1992cited by this paper
• Effects of acute insulin-induced hypoglycaemia on haemostasis, fibrinolysis and haemorheology in insulin-dependent diabetic patients and control subjects.

  1991cited by this paper
• The effect of α‐adrenergic blockade on responses of peripheral blood cells to acute insulin‐induced hypoglycaemia in humans

  1990cited by this paper
• Effect of α2-adrenoceptor antagonist on platelet activation during insulin-induced hypoglycaemia in Type 2 (non-insulin-dependent) diabetes mellitus

  1988cited by this paper

• The impact of GLP-1 and incretin-based therapies on counterregulatory responses to hypoglycemia in diabetes mellitus: mechanisms and clinical implications.

  2026cites this paper
• Transient neurovascular coupling impairment in brain penetrating arterioles of streptozotocin treated mice post recurrent nonsevere hypoglycemia

  2025cites this paper
• Hypoglycemia: Updates on Diagnosis and Treatment

  2025cites this paper
• Development and validation of a novel nomogram incorporating psychosocial factors for predicting hypoglycemia during perioperative period of digestive endoscopy (DREAM-Hypo Model)

  2025cites this paper
• Movement Disorder Following Hypoglycemic Encephalopathy in Mitochondrial 3-Hydroxy-3-methylglutaryl-CoA Synthase-2 (mHS) Deficiency

  2025cites this paper
• Impact of a Specialized Team in Diabetes on Glucometric Parameters and Efficiency Indicators During Hospital Admission in Medical Units

  2025cites this paper
• Deciphering the brain glucose metabolism: A gateway to innovative stroke therapies

  2025cites this paper
• Recurrent hypoglycemia exposure increases the risk of platelet activation and thrombosis in insulin‐treated diabetic rats

  2025cites this paper
• Enhanced risk of thrombosis in aged insulin-treated diabetic rats exposed to non-severe recurrent hypoglycemia

  2025cites this paper
• Review Article – Diabetes Technology in the Hospital: An Update

  2024cites this paper
• Relationship between glycated hemoglobin levels and three-month outcomes in acute ischemic stroke patients with or without diabetes: a prospective Korean cohort study

  2024cites this paper
• Взаимосвязь гипогликемии и когнитивных нарушений у пожилых пациентов с сахарным диабетом 2 типа

  2024cites this paper
• Hipoglikémia időskorban: változatlan fontosságú, de egyre inkább megelőzhető szövődmény

  2024cites this paper
• The fuzzy MAD stroke conjecture, using Fuzzy C Means to classify multimodal apparent diffusion for ischemic stroke lesion stratification

  2024cites this paper
• Association of Admission Glucose and Outcomes After Endovascular Treatment for Acute Stroke: Data From the ANGEL-ACT Registry

  2023cites this paper
• The Prognostic Significance of Early Glycemic Profile in Acute Ischemic Stroke Depends on Stroke Subtype

  2023cites this paper
• Predicting short-term outcomes in atrial-fibrillation-related stroke using machine learning

  2023cites this paper
• Acute severe hypoglycemia alters mouse brain microvascular proteome

  2023cites this paper
• Association of underlying untreated cardiovascular risk factors with mortality and functional outcome in ischaemic stroke patients.

  2023cites this paper
• Association of diabetes mellitus and admission glucose levels with outcome after endovascular therapy in acute ischaemic stroke in anterior circulation

  2022cites this paper
• Expert Consensus on Cognitive Dysfunction in Diabetes

  2022cites this paper
• Predicting Role of Prestroke Glycemic Variability Estimated by Glycated Albumin for Reperfusion and Prognosis after Endovascular Treatment

  2022cites this paper
• Managing TIA: Early action and essential risk-reduction steps.

  2022cites this paper
• Hypoglycemia in type 2 diabetes mellitus patients — cerebral, cognitive, psychosocial and clinical aspects

  2022cites this paper
• Hypoglycemia-Induced Basal Ganglia Infarct: A Rare Case of Metformin Toxicity in a Hemodialysis Patient

  2022influential citation
• Sex-related disparities in the incidence and outcomes of hemorrhagic stroke among type 2 diabetes patients: a propensity score matching analysis using the Spanish National Hospital Discharge Database for the period 2016–18

  2021cites this paper
• Prestroke Glucose Control and Functional Outcome in Patients With Acute Large Vessel Occlusive Stroke and Diabetes After Thrombectomy

  2021cites this paper
• Potential Biomarkers to Predict Acute Ischemic Stroke in Type 2 Diabetes

  2021cites this paper
• Glycemic Control in Hospitalized Stroke Patients: A Review

  2021cites this paper
• Evaluation of risk factors and correlation in large sample from the perspective of hypoglycemia

  2021cites this paper
• Diabetic patients awareness toward hypoglycemia attacks in Al Jouf region, Saudi Arabia

  2021cites this paper
• Diabetes, Vascular Aging and Stroke: Old Dogs, New Tricks?

  2021influential citation
• A model to predict risk of stroke in middle-aged adults with type 2 diabetes generated from a nationwide population-based cohort study in Korea.

  2020cites this paper
• Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational study

  2020cites this paper
• Diabetes mellitus erhöht das Risiko für einen Schlaganfall

  2020cites this paper
• Inpatient Hypoglycemia: The Challenge Remains

  2020cites this paper
• Hypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes

  2020cites this paper
• Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus.

  2019cites this paper
• IDENTIFICATION OF PROGNOSTIC FACTORS FOR ISCHAEMIC STROKE AND MYOCARDIAL INFARCTION

  2019cites this paper
• Bridging the Gap Between Diabetes and Stroke in Search of High Clinical Relevance Therapeutic Targets

  2019cites this paper
• Severe hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort study

  2019cites this paper
• Association between Clinical and Laboratory Markers and 5-year Mortality among Patients with Stroke

  2019cites this paper
• Evolving Evidence of Calreticulin as a Pharmacological Target in Neurological Disorders.

  2019cites this paper
• Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management.

  2019cites this paper